277 related articles for article (PubMed ID: 29945909)
1. Short- and Long-Term Reliability of the 6-Minute Walk Test in People With Idiopathic Pulmonary Fibrosis.
Holland AE; Hill CJ; Dowman L; Glaspole I; Goh N; Lee AL; McDonald CF
Respir Care; 2018 Aug; 63(8):994-1001. PubMed ID: 29945909
[TBL] [Abstract][Full Text] [Related]
2. Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.
Agarwala P; Salzman SH
Chest; 2020 Mar; 157(3):603-611. PubMed ID: 31689414
[TBL] [Abstract][Full Text] [Related]
3. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis.
Nathan SD; du Bois RM; Albera C; Bradford WZ; Costabel U; Kartashov A; Noble PW; Sahn SA; Valeyre D; Weycker D; King TE
Respir Med; 2015 Jul; 109(7):914-22. PubMed ID: 25956020
[TBL] [Abstract][Full Text] [Related]
4. Cardiorespiratory adaptation during 6-Minute Walk Test in fibrotic idiopathic interstitial pneumonia patients who did or did not respond to pulmonary rehabilitation.
Chéhère B; Bougault V; Chenivesse C; Grosbois JM; Wallaert B
Eur J Phys Rehabil Med; 2019 Feb; 55(1):103-112. PubMed ID: 29904044
[TBL] [Abstract][Full Text] [Related]
5. Minimal important difference and responsiveness of 2-minute walk test performance in people with COPD undergoing pulmonary rehabilitation.
Johnston KN; Potter AJ; Phillips AC
Int J Chron Obstruct Pulmon Dis; 2017; 12():2849-2857. PubMed ID: 29070945
[TBL] [Abstract][Full Text] [Related]
6. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G; van den Blink B; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Santin-Janin H; Mulder GJ; Bartholmai B; Gupta R; Richeldi L
JAMA; 2018 Jun; 319(22):2299-2307. PubMed ID: 29800034
[TBL] [Abstract][Full Text] [Related]
7. Changes in physical activity in people with idiopathic pulmonary fibrosis before and after virtual pulmonary rehabilitation: a feasibility study.
O'Shea O; Murphy G; Fox L; O'Reilly KMA
BMC Pulm Med; 2024 May; 24(1):215. PubMed ID: 38698361
[TBL] [Abstract][Full Text] [Related]
8. Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.
Serajeddini H; Rogliani P; Mura M
Lung; 2018 Dec; 196(6):707-713. PubMed ID: 30151723
[TBL] [Abstract][Full Text] [Related]
9. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
du Bois RM; Weycker D; Albera C; Bradford WZ; Costabel U; Kartashov A; Lancaster L; Noble PW; Sahn SA; Szwarcberg J; Thomeer M; Valeyre D; King TE
Am J Respir Crit Care Med; 2011 May; 183(9):1231-7. PubMed ID: 21131468
[TBL] [Abstract][Full Text] [Related]
10. Impaired chronotropic response to 6-min walk test and reduced survival in interstitial lung disease.
Holland AE; Hill CJ; Glaspole I; Goh N; Dowman L; McDonald CF
Respir Med; 2013 Jul; 107(7):1066-72. PubMed ID: 23669412
[TBL] [Abstract][Full Text] [Related]
11. Concurrence of 1- and 3-Min Sit-to-Stand Tests with the 6-Min Walk Test in Idiopathic Pulmonary Fibrosis.
Fedi A; Keddache S; Quétant S; Guillien A; Antoniadis A; Soumagne T; Ritter O; Glérant JC; Cottin V; Degano B; Aguilaniu B
Respiration; 2021; 100(7):571-579. PubMed ID: 33849043
[TBL] [Abstract][Full Text] [Related]
12. Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis.
Rammaert B; Leroy S; Cavestri B; Wallaert B; Grosbois JM
Rev Mal Respir; 2011 Sep; 28(7):e52-7. PubMed ID: 21943547
[TBL] [Abstract][Full Text] [Related]
13. Features and predictive value of 6-min walk test outcomes in interstitial lung disease: an observation study using wearable monitors.
Li J; Li X; Deng M; Liang X; Wei H; Wu X
BMJ Open; 2022 Jun; 12(6):e055077. PubMed ID: 35705338
[TBL] [Abstract][Full Text] [Related]
14. The 6-minute walk distance cannot be accurately assessed at home in people with COPD.
Holland AE; Rasekaba T; Fiore JF; Burge AT; Lee AL
Disabil Rehabil; 2015; 37(12):1102-6. PubMed ID: 25176002
[TBL] [Abstract][Full Text] [Related]
15. Physiological Profile and Limitations in Exercise in Idiopathic Pulmonary Fibrosis.
Vainshelboim B; Oliveira J; Fox BD; Adir Y; Ollech JE; Kramer MR
J Cardiopulm Rehabil Prev; 2016; 36(4):270-8. PubMed ID: 27120038
[TBL] [Abstract][Full Text] [Related]
16. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial.
Dowman LM; McDonald CF; Hill CJ; Lee AL; Barker K; Boote C; Glaspole I; Goh NSL; Southcott AM; Burge AT; Gillies R; Martin A; Holland AE
Thorax; 2017 Jul; 72(7):610-619. PubMed ID: 28213592
[TBL] [Abstract][Full Text] [Related]
17. Endurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosis.
Arizono S; Taniguchi H; Sakamoto K; Kondoh Y; Kimura T; Kataoka K; Ogawa T; Watanabe F; Nishiyama O; Nishimura K; Kozu R; Tabira K
Respir Care; 2014 Jul; 59(7):1108-15. PubMed ID: 24327743
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis.
Nolan CM; Maddocks M; Maher TM; Canavan JL; Jones SE; Barker RE; Patel S; Jacob J; Cullinan P; Man WD
Respirology; 2018 May; 23(5):498-506. PubMed ID: 29139195
[TBL] [Abstract][Full Text] [Related]
19. Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis.
Bahmer T; Kirsten AM; Waschki B; Rabe KF; Magnussen H; Kirsten D; Gramm M; Hummler S; Brunnemer E; Kreuter M; Watz H
BMC Pulm Med; 2017 Jul; 17(1):104. PubMed ID: 28743305
[TBL] [Abstract][Full Text] [Related]
20. Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
Kozu R; Jenkins S; Senjyu H; Mukae H; Sakamoto N; Kohno S
Respirology; 2010 May; 15(4):706-13. PubMed ID: 20409022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
